Bodey G P, Weaver S, Pan T
J Antibiot (Tokyo). 1977 Sep;30(9):724-9. doi: 10.7164/antibiotics.30.724.
The in vitro activity of a new semi-synthetic penicillin, CP-35,587, 3-(5-tetrazolyl) penam, was investigated against 496 clinical isolates of gram-negative bacilli and 113 clinical isolates of gram-positive cocci. All of the gram-positive cocci were sensitive to CP-35,587 except penicillin G resistant isolates of Staphylococcus aureus. This antibiotic inhibited a majority of isolates of Escherichia coli, Klebsiella spp. and Proteus mirabilis at a concentration of 6.25 microgram/ml. Also, approximately half of the isolates of Serratia marcescens and Enterobacter spp. were inhibited at a concentration of 12.5 microgram/ml. CP-35,587 was inactive when high concentrations of organisms were used as inocula. CP-35,587 was more active than mezlocillin, azlocillin, amoxicillin, ticarcillin and carbenicillin against isolates of K. pneumoniae, but other penicillins were more acte than CP-35,587 against other species of gram-negative bacilli.
对一种新型半合成青霉素CP-35587(3-(5-四唑基)青霉烷酸)针对496株革兰氏阴性杆菌临床分离株和113株革兰氏阳性球菌临床分离株的体外活性进行了研究。除了对青霉素G耐药的金黄色葡萄球菌分离株外,所有革兰氏阳性球菌对CP-35587均敏感。这种抗生素在浓度为6.25微克/毫升时能抑制大多数大肠杆菌、克雷伯菌属和奇异变形杆菌分离株。此外,在浓度为12.5微克/毫升时,大约一半的粘质沙雷氏菌和肠杆菌属分离株受到抑制。当使用高浓度的菌液作为接种物时,CP-35587无活性。在针对肺炎克雷伯菌分离株方面,CP-35587比美洛西林、阿洛西林、阿莫西林、替卡西林和羧苄西林更具活性,但在针对其他革兰氏阴性杆菌菌种时,其他青霉素比CP-35587更具活性。